Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Physio-Control Class I Recall Unrelated To Broader Quality Issues, Firm Says

This article was originally published in The Gray Sheet

Executive Summary

Physio-Control's Class I recall of 249 LifePak CR Plus automated external defibrillators, initiated Aug. 28, will not derail efforts to resolve long-standing quality deficiencies under an April FDA consent decree, the company says
Advertisement

Related Content

Regulatory News In Brief
Regulatory News In Brief
Medtronic Enters Into FDA Consent Decree Over Physio-Control Quality Issues
Medtronic Enters Into FDA Consent Decree Over Physio-Control Quality Issues
Advertisement
UsernamePublicRestriction

Register

MT026572

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel